Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
LAKE FOREST, Ill., and PETACH TIKVA, Israel, Jan. 22, 2013 /PRNewswire/ -- Hospira, Inc.  (NYSE: HSP ), the world's leading provider of injectable drugs and infusion technologies, and Q Core Medical, Ltd., an innovation leader in infusion delivery systems, today announced that the companies have entered into a distribution agreement for the Q Core Sapphire™ multi-therapy infusion system. Through the arrangement, Hospira will have exclusive rights to market and distribute Sapphire -- a compact and lightweight infusion device system frequently used in ambulatory and hospital settings -- in more than 60 key markets across Europe, Asia and The Americas. The agreement also enables Hospira to collaborate with Q Core for distribution of its product development pipeline.
(Photo - http://photos.prnewswire.com/prnh/20130122/CG45348 )
"Collaborating with Q Core reinforces Hospira's commitment to providing advanced infusion systems that help improve the safety and efficiency of I.V. (intravenous) medication administration," said Julie Sawyer Montgomery , vice president, Medication Management Systems Marketing, Hospira. "With clinicians in multiple regions using the Sapphire system to support their medication administration needs, the device expands Hospira's ability to help support patient safety in key geographies."
The Sapphire system satisfies a wide range of critical drug delivery needs in ambulatory and hospital care environments and readily adapts to emerging needs. It features a full-color touch-screen and software designed to enable intuitive programming and operation with minimal steps. The smart pump capabiliti